These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Kaposi's sarcoma-associated herpesvirus (KSHV) latency-associated nuclear antigen regulates the KSHV epigenome by association with the histone demethylase KDM3A. Kim KY; Huerta SB; Izumiya C; Wang DH; Martinez A; Shevchenko B; Kung HJ; Campbell M; Izumiya Y J Virol; 2013 Jun; 87(12):6782-93. PubMed ID: 23576503 [TBL] [Abstract][Full Text] [Related]
24. NDRG1 facilitates the replication and persistence of Kaposi's sarcoma-associated herpesvirus by interacting with the DNA polymerase clamp PCNA. Zhang F; Liang D; Lin X; Zou Z; Sun R; Wang X; Liang X; Kaye KM; Lan K PLoS Pathog; 2019 Feb; 15(2):e1007628. PubMed ID: 30811506 [TBL] [Abstract][Full Text] [Related]
25. Bub1 and CENP-F can contribute to Kaposi's sarcoma-associated herpesvirus genome persistence by targeting LANA to kinetochores. Xiao B; Verma SC; Cai Q; Kaul R; Lu J; Saha A; Robertson ES J Virol; 2010 Oct; 84(19):9718-32. PubMed ID: 20660191 [TBL] [Abstract][Full Text] [Related]
26. Kaposi's sarcoma herpesvirus latency-associated nuclear antigen broadly regulates viral gene expression and is essential for lytic infection. Li S; Wang M; Van Sciver N; Szymula A; Tumuluri VS; George A; Ramachandran A; Raina K; Costa CN; Zhao B; Kazemian M; Simas JP; Kaye KM PLoS Pathog; 2024 Jan; 20(1):e1011907. PubMed ID: 38232124 [TBL] [Abstract][Full Text] [Related]
27. Genetic disruption of KSHV major latent nuclear antigen LANA enhances viral lytic transcriptional program. Li Q; Zhou F; Ye F; Gao SJ Virology; 2008 Sep; 379(2):234-44. PubMed ID: 18684478 [TBL] [Abstract][Full Text] [Related]
28. Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus (KSHV) upregulates survivin expression in KSHV-Associated B-lymphoma cells and contributes to their proliferation. Lu J; Verma SC; Murakami M; Cai Q; Kumar P; Xiao B; Robertson ES J Virol; 2009 Jul; 83(14):7129-41. PubMed ID: 19439469 [TBL] [Abstract][Full Text] [Related]
29. Induction of Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen by the lytic transactivator RTA: a novel mechanism for establishment of latency. Lan K; Kuppers DA; Verma SC; Sharma N; Murakami M; Robertson ES J Virol; 2005 Jun; 79(12):7453-65. PubMed ID: 15919901 [TBL] [Abstract][Full Text] [Related]
30. Kaposi's sarcoma-associated herpesvirus-encoded LANA down-regulates IL-22R1 expression through a cis-acting element within the promoter region. Su L; Liao Q; Wu Y; Chen X PLoS One; 2011 Apr; 6(4):e19106. PubMed ID: 21544244 [TBL] [Abstract][Full Text] [Related]
31. Murine Gammaherpesvirus 68 Expressing Kaposi Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen (LANA) Reveals both Functional Conservation and Divergence in LANA Homologs. Gupta A; Oldenburg DG; Salinas E; White DW; Forrest JC J Virol; 2017 Oct; 91(19):. PubMed ID: 28747501 [TBL] [Abstract][Full Text] [Related]
32. Characterization of de novo lytic infection of dermal lymphatic microvascular endothelial cells by Kaposi's sarcoma-associated herpesvirus. Golas G; Alonso JD; Toth Z Virology; 2019 Oct; 536():27-31. PubMed ID: 31394409 [TBL] [Abstract][Full Text] [Related]
33. Transcriptome analysis of Kaposi's sarcoma-associated herpesvirus during de novo primary infection of human B and endothelial cells. Purushothaman P; Thakker S; Verma SC J Virol; 2015 Mar; 89(6):3093-111. PubMed ID: 25552714 [TBL] [Abstract][Full Text] [Related]
34. A comparative epigenome analysis of gammaherpesviruses suggests cis-acting sequence features as critical mediators of rapid polycomb recruitment. Günther T; Fröhlich J; Herrde C; Ohno S; Burkhardt L; Adler H; Grundhoff A PLoS Pathog; 2019 Oct; 15(10):e1007838. PubMed ID: 31671162 [TBL] [Abstract][Full Text] [Related]
35. LANA oligomeric architecture is essential for KSHV nuclear body formation and viral genome maintenance during latency. De Leo A; Deng Z; Vladimirova O; Chen HS; Dheekollu J; Calderon A; Myers KA; Hayden J; Keeney F; Kaufer BB; Yuan Y; Robertson E; Lieberman PM PLoS Pathog; 2019 Jan; 15(1):e1007489. PubMed ID: 30682185 [TBL] [Abstract][Full Text] [Related]
36. Differential regulation of the overlapping Kaposi's sarcoma-associated herpesvirus vGCR (orf74) and LANA (orf73) promoters. Jeong J; Papin J; Dittmer D J Virol; 2001 Feb; 75(4):1798-807. PubMed ID: 11160678 [TBL] [Abstract][Full Text] [Related]
37. Concurrent expression of latent and a limited number of lytic genes with immune modulation and antiapoptotic function by Kaposi's sarcoma-associated herpesvirus early during infection of primary endothelial and fibroblast cells and subsequent decline of lytic gene expression. Krishnan HH; Naranatt PP; Smith MS; Zeng L; Bloomer C; Chandran B J Virol; 2004 Apr; 78(7):3601-20. PubMed ID: 15016882 [TBL] [Abstract][Full Text] [Related]
38. A lytic viral long noncoding RNA modulates the function of a latent protein. Campbell M; Kim KY; Chang PC; Huerta S; Shevchenko B; Wang DH; Izumiya C; Kung HJ; Izumiya Y J Virol; 2014 Feb; 88(3):1843-8. PubMed ID: 24257619 [TBL] [Abstract][Full Text] [Related]
39. The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus supports latent DNA replication in dividing cells. Hu J; Garber AC; Renne R J Virol; 2002 Nov; 76(22):11677-87. PubMed ID: 12388727 [TBL] [Abstract][Full Text] [Related]
40. A novel KRAB-Zinc finger protein interacts with latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus and activates transcription via terminal repeat sequences. Watanabe A; Higuchi M; Fukushi M; Ohsawa T; Takahashi M; Oie M; Fujii M Virus Genes; 2007 Apr; 34(2):127-36. PubMed ID: 17143723 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]